The Licensing and Intellectual Property Department of JINR announces that in December 2017, the Joint Institute for Nuclear Research received a patent for the invention “Way of prevention of psychoneurological status disorders in acute radiation syndrome during the experiment”. The authors of the work are Krasavin E.A., Lyakhova K.N., Severyukhin Yu.S., Molokanov A.G.

JINR staff congratulates the authors on receiving the patent for their invention!

More details about the invention

The invention belongs to experimental medicine and may be applied in cosmonautics for supporting high level of operator performance of astronauts in the environment of unpredictable radiation exposure as well as for patients’ rehabilitation after proton therapy of brain tumours. After a single uneven proton irradiation at the doze sufficient for causing radiation syndrome, an animal receives intranasal injection of Nasal Drops Semax 0,1%. One drop of Semax is injected in each animal’s nostril 3 times a day from the first to the seventh days after irradiation. This therapy provides preservation of normal orientational and research reaction, emotional state, balance between CNS ignitions and depressions damaged by proton radiation.